Description
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
Product Unit Size | Cost | Quantity | Stock |
---|
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
Cas No. | 1170354-22-9 |
---|---|
Purity | ≥95% |
Formula | C28H22F2O6 |
Formula Wt. | 492.47 |
Chemical Name | (1E,6E)-1,7-bis-(4-hydroxy-3-methosyphenyl) hepta-1,6-diene [4(3,4-difluorobenzaldehyde)]-3,5-dione |
IUPAC Name | (1E,6E)-4-[(3,4-difluorophenyl)methylidene]-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione |
Synonym | Difluorobenzocurcumin, 3,4-Difluorobenzocurcumin, CDF |
Melting Point | 214-217°C |
Solubility | DMSO, 110mg/mL |
Appearance | Bright Yellow Powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures | |
Okuda KS, Ng MF, Ruslan NF, et al. 3,4-Difluorobenzocurcumin inhibits Vegfc-Vegfr3-Erk signalling to block developmental lymphangiogenesis in zebrafish. Pharmaceuticals (Basel). 2021 Jun 26;14(7):614. PMID: 34206901.
CDK9 inhibitor.
Endogenous vitamin D prodrug.
Endogenous peptide, involved in water/Na+ homeo...
Phase II enzyme inducer; Nrf2 activator; antiox...
Endogenous peptide fragment, involved in vasoco...
JAK1/2 inhibitor.
Walrycin response regulator inhibitor.
Quinoline; PDE 3B inhibitor.
Calcium channel blocker.
Galactose analog, allolactose mimic, induces ac...
Polyphenol found in Camilla sinensis; HIV integ...
SYK/JAK inhibitor
Endogenous neuropeptide, involved in energy hom...
H+/K+ ATPase inhibitor.
Polyphenolic hydroxystilbene, resveratrol deri...
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
Synthetic isoflavone.
Tetracycline; protein translation inhibitor.
Prodrug of the compound mycophenolic acid.
Mycotoxin contaminant in food and feed.